Fairfield Financial Advisors, LTD
- SEC CIK
- 0002033232
- Latest filing
- Aug 11, 2026
CRSP holding history
CRISPR Therapeutics AG in every 13F filed by Fairfield Financial Advisors, LTD, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −61−100.0% | Sold out | Holders |
| Q1 2023 | 61 | $2.69K | <0.1% | −56−47.9% | Reduced | Holders |
| Q4 2022 | 117 | $4.76K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 117 | $7.65K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 117 | $7.11K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 117 | $7.34K | <0.1% | – | No prior filing | Holders |